News

Nagarkatti joined the company in 1976 and held roles in R&D, production, operations and sales before being elected president and chief operating officer in 2004. Toan is the

Under the partnership agreement, BG Medicine has granted Philips preferential access to certain of its proprietary technologies and services, and Philips has acquired a minority stake in BG

Bringing together respected scientists from related fields, the board will draw upon its members’ unique expertise to offer strategic counsel to the company. The board’s first priority is

The Tissue Repair Company’s (TRC) growth factor therapeutics have the potential to help heal tissue wounds such as dermal ulcers, which affect millions of diabetic patients. The assets

The strategic review, conducted by the board in conjunction with the company’s financial advisors and management, was initiated in January and included the evaluation of a number of

In preclinical studies, ATHX-105 has demonstrated a significant reduction of food intake and weight loss in established obesity models and a good safety profile across multiple animal species.

Glucose RapidSpray delivers a fat-free, low-calorie glucose formulation that was developed using the company’s proprietary buccal drug delivery technologies. The product delivers glucose directly into the mouth where

Until now it was believed that Herceptin (trastuzumab) combined with cytotoxic drug therapy was effective only in HER-2-positive, or HER-2-overexpressing, breast cancer – which represents about 25% of

The conclusion was drawn after an interim analysis of 30 patients treated with a 4ml dose of AVR118, as well as an additional three patients treated with a